Kurt Abenthum
About Kurt Abenthum
Kurt Abenthum is the Associate Director of Global Regulatory Sciences at Bristol Myers Squibb, with over two decades of experience in regulatory affairs and pharmaceutical quality control.
Title and Current Position
Kurt Abenthum is currently an Associate Director in Global Regulatory Sciences at Bristol Myers Squibb. He has been with the company since July 2020, actively involved in regulatory science operations. His role includes overseeing regulatory strategies and ensuring adherence to regulatory standards within the pharmaceutical industry.
Previous Employment and Experience
Kurt Abenthum has over two decades of experience in regulatory affairs and pharmaceutical quality control. His career includes positions such as Manager of Regulatory Affairs at Daiichi Sankyo Deutschland GmbH and biosyn Arzneimittel GmbH. He also worked as a DRA-Manager at Boehringer Ingelheim for three years and held a quality control role at SmithKline Beecham in Herrenberg for nearly a year.
Education and Academic Background
Kurt Abenthum has a robust educational background in biology. He achieved his Dr. rer. nat. in general biology from Eberhard Karls Universität Tübingen, where he also completed a Diplom degree. Additionally, he studied at Arizona State University for a year and earned a Vor-Diplom from Universität Konstanz after two years of study.
Role at Bristol Myers Squibb
Prior to his current role as an Associate Director in Global Regulatory Sciences, Kurt Abenthum was actively involved as a Manager in Global Regulatory Sciences at Bristol Myers Squibb, located in the Munich area. His responsibilities included developing and implementing regulatory strategies to support the company's global initiatives.